J&J Consumer Health On Solid Footing With Help From Personal Care Sales

Analysts say firm’s consumer health division is showing signs of a comeback, with worldwide sales up 5.3% to $3.4bn, boosted 3.7% from currency exchange on strong beauty segment sales, driven by increased online marketing, and strengthening OTC drug sales.

Johnson & Johnson's consumer health business may have turned the corner on its recovery from manufacturing struggles that ended nearly three years ago with a clean bill of health from FDA as orders for OTC drugs increase and e-commerce boosts for personal care product sales.

Analysts say J&J's consumer business results for the first quarter were "encouraging" for its long-term outlook after its worldwide consumer...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Marketing & Advertising

More from Compliance